Source of tumorigenicity 2 (ST2), also known as soluble ST2 or interleukin-1 receptor-like 1 (IL-1RL1), is a biomarker that has shown promise in the early detection and risk stratification of heart diseases, particularly heart failure. Here, IL1RL1 is linked to heart failure.